Skip to the page

Data / Drug companies / Prodose, Inc.

Prodose, Inc.: 66 products in the FDA NDC directory, labeler code 68210

Prodose, Inc. (labeler code 68210) lists 66 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 43 drugs for further processing, 23 over the counter drugs. Its main marketing category is drugs for further processing. The newest product started marketing on July 31, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68210
Products in commercial distribution
66
Packages
83
Finished drugs by generic name
9
Prescription products
0
Over the counter products
23
Flagged as original packager
23 of 23 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
January 5, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Drugs for further processing4365.2%
Generic drugs (ANDA)1624.2%
Over the counter monograph drugs710.6%

Products by type

TypeProductsShare
Drugs for further processing4365.2%
Over the counter drugs2334.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Capsule, liquid filled2334.8%
Tablet, film coated2334.8%
Capsule, gelatin coated812.1%
Tablet69.1%
Tablet, coated23%
Capsule11.5%
Tablet, film coated, extended release11.5%
Solution/ drops11.5%
Spray11.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Acetaminophen, dextromethorphan hydrobromide68210-5078Capsule, liquid filledDrugs for further processingJuly 31, 2026
Acetaminophen 250mg, aspirin 250mg and caffeine 65mg soft gelatin capsules(gel tabs)68210-5070Tablet, coatedDrugs for further processingMay 11, 2026
Dextromethorphan hydrobromide68210-5060Capsule, liquid filledDrugs for further processingMarch 3, 2026
Docusate sodium and sennosides68210-5066Capsule, liquid filledDrugs for further processingFebruary 2, 2026
Omega-3 fish oil68210-5069CapsuleDrugs for further processingJanuary 30, 2026
Value Health by Prodose Eye Drops68210-5059Solution/ dropsOver the counter monograph drugsSeptember 29, 2025
Guaifenesin,dextromethorphan hbr68210-5058Capsule, liquid filledDrugs for further processingSeptember 16, 2025
Oxymetazoline hydrochloride68210-5056SprayOver the counter monograph drugsSeptember 3, 2025
Diphenhydramine hydrochloride68210-5057Capsule, liquid filledOver the counter monograph drugsJuly 30, 2025
Acetaminophen, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride68210-5053Capsule, liquid filledOver the counter monograph drugsJuly 29, 2025
Dextromethorphan hydrobromide68210-5054Capsule, liquid filledDrugs for further processingJuly 18, 2025
Acetaminophen68210-5055Capsule, liquid filledDrugs for further processingJuly 17, 2025
Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate and phenylephrine hydrochloride68210-5050Capsule, liquid filledDrugs for further processingJuly 16, 2025
Guaifenesin,dextromethorphan hbr68210-5044Capsule, liquid filledDrugs for further processingJuly 16, 2025
Acetaminophen, dextromethorphan hbr, guaifenesin68210-5052Tablet, film coatedDrugs for further processingJuly 7, 2025
Acetaminophen, dextromethorphan hbr and doxylamine succinate68210-5062Capsule, liquid filledDrugs for further processingJune 25, 2025
Acetaminophen, dextromethorphan hbr ,guaifenesin68210-5061Capsule, liquid filledDrugs for further processingJune 25, 2025
Docusate sodium and sennosides68210-5051Capsule, liquid filledDrugs for further processingJune 25, 2025
Acetaminophen68210-5047Capsule, liquid filledDrugs for further processingJune 12, 2025
Diphenhydramine hydrochloride68210-5046Capsule, liquid filledDrugs for further processingJune 11, 2025
Diphenhydramine hydrochloride68210-5045Capsule, liquid filledDrugs for further processingMay 6, 2025
Acetaminophen, dextromethorphan hbr and phenylephrine hcl68210-5064Capsule, liquid filledDrugs for further processingApril 9, 2025
Acetaminophen, dextromethorphan hydrobromide and doxylamine succinate68210-5042Capsule, liquid filledDrugs for further processingApril 9, 2025
Guaifenesin and dextromethorphan hbr68210-5041Capsule, gelatin coatedDrugs for further processingApril 9, 2025
Allergy Relief68210-4230Tablet, film coatedGeneric drugs (ANDA)November 16, 2022

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.